Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2.

Bhagirath D, Yang TL, Tabatabai ZL, Majid S, Dahiya R, Tanaka Y, Saini S.

Clin Cancer Res. 2019 Aug 1. doi: 10.1158/1078-0432.CCR-19-0498. [Epub ahead of print]

PMID:
31371344
2.

Practice Patterns in Urinary Cytopathology Prior to the Paris System for Reporting Urinary Cytology.

Barkan GA, Tabatabai ZL, Kurtycz DFI, Padmanabhan V, Souers RJ, Nayar R, Sturgis CD.

Arch Pathol Lab Med. 2019 Jul 11. doi: 10.5858/arpa.2019-0045-CP. [Epub ahead of print]

PMID:
31295017
3.

Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer.

Hashimoto Y, Shiina M, Dasgupta P, Kulkarni P, Kato T, Wong RK, Tanaka Y, Shahryari V, Maekawa S, Yamamura S, Saini S, Deng G, Tabatabai ZL, Majid S, Dahiya R.

Cancer Prev Res (Phila). 2019 Sep;12(9):585-598. doi: 10.1158/1940-6207.CAPR-18-0509. Epub 2019 Jul 2.

PMID:
31266828
4.

NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6-13 C2 ]glucose.

Bancroft Brown J, Sriram R, VanCriekinge M, Delos Santos R, Sun J, Delos Santos J, Tabatabai ZL, Shinohara K, Nguyen H, Peehl DM, Kurhanewicz J.

Magn Reson Med. 2019 Aug;82(2):566-576. doi: 10.1002/mrm.27739. Epub 2019 Mar 28.

PMID:
30924180
5.

Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression.

Bhagirath D, Yang TL, Tabatabai ZL, Shahryari V, Majid S, Dahiya R, Tanaka Y, Saini S.

Carcinogenesis. 2019 Jul 4;40(5):633-642. doi: 10.1093/carcin/bgz058.

PMID:
30874288
6.

Ischemic Fasciitis Mimicking A Lipoma.

Saeed L, Bahrani E, Lauw MIS, Tabatabai ZL, Arron ST, Mauro TM.

Dermatol Surg. 2019 Feb 14. doi: 10.1097/DSS.0000000000001853. [Epub ahead of print] No abstract available.

PMID:
30789504
7.

Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.

Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y.

Oncotarget. 2018 Sep 25;9(75):34190. doi: 10.18632/oncotarget.26197. eCollection 2018 Sep 25.

8.

Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks.

Chan E, Balassanian R, Tabatabai ZL, Lou H, Vohra P.

Cancer Cytopathol. 2018 Sep;126(9):809-816. doi: 10.1002/cncy.22034. Epub 2018 Sep 11.

9.

Low-Grade Squamous Intraepithelial Lesion or High-Grade Squamous Intraepithelial Lesion? Concordance Between the Interpretation of Low-Grade Squamous Intraepithelial Lesion and High-Grade Squamous Intraepithelial Lesion in Papanicolaou Tests: Results From the College of American Pathologists PAP Education Program.

Crothers BA, Ghofrani M, Zhao C, Dodd LG, Goodrich K, Husain M, Kurtycz DFI, Russell DK, Shen RZ, Souers RJ, Staats PN, Tabatabai ZL, Witt BL, Davey DD.

Arch Pathol Lab Med. 2019 Jan;143(1):81-85. doi: 10.5858/arpa.2018-0003-CP. Epub 2018 Aug 22.

PMID:
30133317
10.

Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer.

Kato T, Hashimoto Y, Wong RK, Mitsui Y, Maekawa S, Chang I, Shahryari V, Yamamura S, Majid S, Saini S, Tabatabai ZL, Dahiya R, Deguchi T, Tanaka Y.

J Cell Mol Med. 2018 Oct;22(10):4676-4687. doi: 10.1111/jcmm.13696. Epub 2018 Aug 22.

11.

Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression.

Kulkarni P, Dasgupta P, Bhat NS, Shahryari V, Shiina M, Hashimoto Y, Majid S, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R.

Mol Cancer Res. 2018 Nov;16(11):1750-1760. doi: 10.1158/1541-7786.MCR-17-0762. Epub 2018 Jul 23.

PMID:
30037856
12.

Correction: Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.

Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Dahiya R.

Br J Cancer. 2018 Aug;119(3):388. doi: 10.1038/s41416-018-0146-2.

13.

Performance Characteristics of Cerebrospinal Fluid Cytology: An Analysis of Responses From the College of American Pathologists Nongynecologic Cytopathology Education Program.

Tabatabai ZL, Auger M, Souers RJ, Teot L, Davey DD.

Arch Pathol Lab Med. 2018 Jul;142(7):833-837. doi: 10.5858/arpa.2017-0167-CP. Epub 2018 Apr 6.

PMID:
29624076
14.

MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.

Dasgupta P, Kulkarni P, Majid S, Shahryari V, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R.

Mol Cancer Ther. 2018 May;17(5):1061-1069. doi: 10.1158/1535-7163.MCT-17-0925. Epub 2018 Feb 13.

15.

Performance Characteristics of Body Fluid Cytology Analysis of 344‚ÄČ380 Responses From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology.

Tabatabai ZL, Nayar R, Souers RJ, Crothers BA, Davey DD.

Arch Pathol Lab Med. 2018 Jan;142(1):53-58. doi: 10.5858/arpa.2016-0509-CP. Epub 2017 Oct 19.

PMID:
29048220
16.

Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.

Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y.

Oncotarget. 2017 Jun 13;8(24):39087-39100. doi: 10.18632/oncotarget.16598. Erratum in: Oncotarget. 2018 Sep 25;9(75):34190.

17.

False-Negative Interpretation of Adenocarcinoma In Situ in the College of American Pathologists Gynecologic PAP Education Program.

Zhao C, Crothers BA, Tabatabai ZL, Li Z, Ghofrani M, Souers RJ, Husain M, Fan F, Shen R, Ocal IT, Booth CN, Goodrich K, Russell D, Davey DD; College of American Pathologists Cytopathology Committee.

Arch Pathol Lab Med. 2017 May;141(5):666-670. doi: 10.5858/arpa.2016-0234-CP. Epub 2017 Mar 16.

PMID:
28301226
18.

Adequacy of voided urine specimens prepared by ThinPrep and evaluated using The Paris System for Reporting Urinary Cytology.

Rezaee N, Tabatabai ZL, Olson MT.

J Am Soc Cytopathol. 2017 Jul - Aug;6(4):155-161. doi: 10.1016/j.jasc.2017.04.001. Epub 2017 May 5.

PMID:
31043268
19.

MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.

Bucay N, Sekhon K, Yang T, Majid S, Shahryari V, Hsieh C, Mitsui Y, Deng G, Tabatabai ZL, Yamamura S, Calin GA, Dahiya R, Tanaka Y, Saini S.

Oncogene. 2017 May 11;36(19):2667-2679. doi: 10.1038/onc.2016.419. Epub 2016 Nov 28.

20.

In Reply.

Kurtycz DF, Auger M, Laucirica R, Tabatabai ZL.

Arch Pathol Lab Med. 2016 Nov;140(11):1183-1184. No abstract available.

PMID:
27788044
21.

Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.

Nip H, Dar AA, Saini S, Colden M, Varahram S, Chowdhary H, Yamamura S, Mitsui Y, Tanaka Y, Kato T, Hashimoto Y, Shiina M, Kulkarni P, Dasgupta P, Imai-Sumida M, Tabatabai ZL, Greene K, Deng G, Dahiya R, Majid S.

Oncotarget. 2016 Oct 18;7(42):68371-68384. doi: 10.18632/oncotarget.12031.

22.

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer.

Bucay N, Sekhon K, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Greene K, Tanaka Y, Dahiya R, Deng G, Saini S.

Oncotarget. 2016 Oct 25;7(43):70388-70403. doi: 10.18632/oncotarget.11865.

23.

Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens.

Zakowski MF, Rekhtman N, Auger M, Booth CN, Crothers B, Ghofrani M, Khalbuss W, Laucirica R, Moriarty AT, Tabatabai ZL, Barkan GA.

Arch Pathol Lab Med. 2016 Oct;140(10):1116-20. doi: 10.5858/arpa.2015-0316-OA. Epub 2016 Aug 23.

24.

Pancreatobiliary duct brushing cytopathology: an analysis of the CAP Non-Gynecologic Cytology (NGC) program for pancreatic pathology 2000-2011.

Kurtycz DFI, Tabatabai ZL, Nayar R, Souers R, Laucirica R, Fraig M, Khalbuss WE.

J Am Soc Cytopathol. 2016 Jan - Feb;5(1):15-21. doi: 10.1016/j.jasc.2015.07.003. Epub 2015 Aug 4.

PMID:
31042533
25.

Respiratory Cytology--Current Trends Including Endobronchial Ultrasound-Guided Biopsy and Electromagnetic Navigational Bronchoscopy: Analysis of Data From a 2013 Supplemental Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology.

Sturgis CD, Marshall CB, Barkan GA, Booth CN, Kurtycz DF, Souers RJ, Keylock JB, Tabatabai ZL, Russell DK, Moriarty AT, Doyle MA, Thomas N, Yildiz-Aktas IZ, Collins BT, Laucirica R, Crothers BA.

Arch Pathol Lab Med. 2016 Jan;140(1):22-8. doi: 10.5858/arpa.2014-0635-CP.

PMID:
26717056
26.

Performance Characteristics of Adenoid Cystic Carcinoma of the Salivary Glands in Fine-Needle Aspirates: Results From the College of American Pathologists Nongynecologic Cytology Program.

Tabatabai ZL, Auger M, Kurtycz DF, Laser A, Souers RJ, Laucirica R, Barkan GA, Crothers BA, Khalbuss WE.

Arch Pathol Lab Med. 2015 Dec;139(12):1525-30. doi: 10.5858/arpa.2013-0173-CP.

PMID:
26619024
27.

miRNA Expression Analyses in Prostate Cancer Clinical Tissues.

Bucay N, Shahryari V, Majid S, Yamamura S, Mitsui Y, Tabatabai ZL, Greene K, Deng G, Dahiya R, Tanaka Y, Saini S.

J Vis Exp. 2015 Sep 8;(103). doi: 10.3791/53123.

28.

Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.

Crothers BA, Darragh TM, Tambouret RH, Nayar R, Barkan GA, Zhao C, Booth CN, Padmanabhan V, Tabatabai ZL, Souers RJ, Thomas N, Wilbur DC, Moriarty AT.

Arch Pathol Lab Med. 2016 Jan;140(1):13-21. doi: 10.5858/arpa.2015-0004-CP. Epub 2015 Jun 5.

PMID:
26046490
29.

Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.

Chang I, Mitsui Y, Fukuhara S, Gill A, Wong DK, Yamamura S, Shahryari V, Tabatabai ZL, Dahiya R, Shin DM, Tanaka Y.

Oncotarget. 2015 Apr 10;6(10):7774-87.

30.

Do liquid-based preparations of pulmonary bronchial brushing specimens perform differently from classically prepared cases for the diagnosis of malignancies? Observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology.

Tabatabai ZL, Auger M, Kurtycz DF, Laucirica R, Souers RJ, Nayar R, Khalbuss WE, Moriarty AT, Fraig M.

Arch Pathol Lab Med. 2015 Feb;139(2):178-83. doi: 10.5858/arpa.2013-0282-CP.

PMID:
25611101
31.

Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R.

Cancer Res. 2015 Apr 1;75(7):1322-31. doi: 10.1158/0008-5472.CAN-14-2931. Epub 2015 Jan 19.

32.

Pancreatic fine-needle aspiration cytopathology: an analysis of the CAP NGC program for pancreatic FNA 2003-2011.

Kurtycz DFI, Tabatabai ZL, Khalbuss WE, Souers R, Padmanabhan V, Fraig M.

J Am Soc Cytopathol. 2015 Nov - Dec;4(6):327-334. doi: 10.1016/j.jasc.2015.03.002. Epub 2015 Mar 20.

PMID:
31051747
33.

SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.

Li Y, Kido T, Garcia-Barcelo MM, Tam PK, Tabatabai ZL, Lau YF.

Hum Mol Genet. 2015 Feb 1;24(3):685-97. doi: 10.1093/hmg/ddu488. Epub 2014 Sep 28.

34.

Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.

Farrell JM, Pang JC, Kim GE, Tabatabai ZL.

Cancer Cytopathol. 2014 Oct;122(10):770-8. doi: 10.1002/cncy.21457. Epub 2014 Jul 9.

35.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S, Saini S, Yamamura S, Chiyomaru T, Hirata H, Ueno K, Arora S, Shahryari V, Deng G, Tabatabai ZL, Greene KL, Shin DM, Enokida H, Shiina H, Nonomura N, Dahiya R, Tanaka Y.

Tumour Biol. 2014 Oct;35(10):10223-30. doi: 10.1007/s13277-014-2292-3. Epub 2014 Jul 17.

PMID:
25027399
36.

The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma.

Kido T, Lo RC, Li Y, Lee J, Tabatabai ZL, Ng IO, Lau YF.

Hum Pathol. 2014 Sep;45(9):1847-58. doi: 10.1016/j.humpath.2014.05.002. Epub 2014 May 23.

PMID:
25017435
37.

Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.

Saini S, Majid S, Shahryari V, Tabatabai ZL, Arora S, Yamamura S, Tanaka Y, Dahiya R, Deng G.

Mol Cancer Ther. 2014 Jul;13(7):1952-63. doi: 10.1158/1535-7163.MCT-14-0017. Epub 2014 May 9.

38.

Postbrushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: the Papanicolaou Society of Cytopathology guidelines.

Kurtycz D, Tabatabai ZL, Michaels C, Young N, Schmidt CM, Farrell J, Gopal D, Simeone D, Merchant NB, Field A, Pitman MB; Papanicolaou Society of Cytopathology.

Diagn Cytopathol. 2014 Apr;42(4):363-71. doi: 10.1002/dc.23121.

39.

Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.

Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Dahiya R.

Br J Cancer. 2014 Mar 18;110(6):1645-54. doi: 10.1038/bjc.2014.48. Epub 2014 Feb 6. Erratum in: Br J Cancer. 2018 Aug;119(3):388.

40.

The role of metabolic imaging in radiation therapy of prostate cancer.

Zhang VY, Westphalen A, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J.

NMR Biomed. 2014 Jan;27(1):100-11. doi: 10.1002/nbm.3007. Epub 2013 Aug 12. Review.

41.

Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.

Hirata H, Ueno K, Nakajima K, Tabatabai ZL, Hinoda Y, Ishii N, Dahiya R.

Br J Cancer. 2013 May 28;108(10):2070-8. doi: 10.1038/bjc.2013.173. Epub 2013 Apr 16.

42.

Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.

Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R.

PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.

43.

microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.

Ueno K, Hirata H, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R.

Br J Cancer. 2013 Apr 30;108(8):1659-67. doi: 10.1038/bjc.2013.125. Epub 2013 Mar 28.

44.

MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.

Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R.

PLoS One. 2013;8(1):e55502. doi: 10.1371/journal.pone.0055502. Epub 2013 Jan 30.

45.

Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R.

PLoS One. 2012;7(11):e51056. doi: 10.1371/journal.pone.0051056. Epub 2012 Nov 30.

46.

The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.

Hyun TS, Barnes M, Tabatabai ZL.

Acta Cytol. 2012;56(5):527-32. doi: 10.1159/000339586. Epub 2012 Sep 27.

PMID:
23075894
47.

MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer.

Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Chiyomaru T, Fukuhara S, Tanaka Y, Deng G, Tabatabai ZL, Dahiya R.

PLoS One. 2012;7(10):e46743. doi: 10.1371/journal.pone.0046743. Epub 2012 Oct 4.

48.

Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.

Chiyomaru T, Yamamura S, Zaman MS, Majid S, Deng G, Shahryari V, Saini S, Hirata H, Ueno K, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Nakagawa M, Dahiya R.

PLoS One. 2012;7(8):e43812. doi: 10.1371/journal.pone.0043812. Epub 2012 Aug 23.

49.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R.

PLoS One. 2012;7(2):e31060. doi: 10.1371/journal.pone.0031060. Epub 2012 Feb 8.

50.

Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Hinoda Y, Dahiya R.

Mol Cancer Ther. 2012 Jan;11(1):244-53. doi: 10.1158/1535-7163.MCT-11-0592. Epub 2011 Nov 4.

Supplemental Content

Loading ...
Support Center